Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Combination of Tafluprost and Timolol (Atc Code: S01ed70).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Chlorthalidone (Atc Code: C03ba04).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Tafluprost (Atc Code: S01ee05).

Open House Drug Discount Contracts Diclofenac, Atc D11ax18

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Rivaroxaban, Atc B01af01 for the Period April 1St, 2024 - March 31St, 2025...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Pyridostigmine (Atc Code: N07aa02).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Rivaroxaban (Atc Code: B01af01).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Filgrastim, Atc L03aa02 for the Period April 1St, 2024 - March 31St, 2026

Open House Drug Discount Agreements Fingolimod in the Potency 0.25 Mg, Atc L04ae01

Open House Drug Discount Agreements Rivaroxaban Hard Capsules (Except in the Strength 2.5 Mg), Atc B01af01